| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.006 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |